Abstract Details

Title High-Dose Immunoablation and Stem Cells Transplantation in Multiple Sclerosis Patients: Twelve-Year Czech Experience

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 193

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Eva Krasulova, MD (Faculty Hospital, MS Center)	No disclosure on file
Melissa L. Heiry, MD (Thomas Jefferson University)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Ivana Kovarova (Teva Pharmaceuticals, s.r.o.)	No disclosure on file
	No disclosure on file
	No disclosure on file
Eva Havrdova, MD (Neurologicka Klinika 1 LF UK)	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.

��ɫ��